Vapi (Gujarat) [India], January 22: Cardiac care has undergone a profound transformation over the last five decades. From the first balloon angioplasty performed in 1977 to today's image-guided, precision-driven interventions, the journey of heart care mirrors the evolution of medicine itsel
Vapi (Maharashtra) [India], November 25: Underscoring India's rising influence in global cardiovascular innovation, Meril Life Sciences presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the Late-Breaking Trial sessions at PCR London Valves 202
Vapi (Gujarat) [India], May 22: Meril Life Sciences announced one-year results from its pivotal LANDMARK trial, presented during the prestigious Late-Breaking Trial session at EuroPCR 2025, one of the world's premier cardiology conferences held annually in Paris, France. The LANDMARK trial i
Vapi (Gujarat) [India], November 27: Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked a significant milestone with the launch of its Myval Octapro Transcatheter Heart Valve (THV) at GISE 2024 (National Congress of th
Vapi (Gujarat) [India], May 16: Exciting news from Meril Life Sciences! The LANDMARK trial's 30 days primary outcomes were presented on 15th May at EuroPCR 2024, Paris, France. LANDMARK was recognized by EuroPCR as one of the top three late breaking trials poised to transform revolutionise c